Summary
The mouse isolated vas deferens is a nerve-smooth muscle preparation that serves as a highly sensitive and quantitative functional in vitro bioassay for cannabinoid CB1 receptor agonists. Additionally, it is commonly used as a bioassay for competitive surmountable CB1 receptor antagonists, and also provides a means for distinguishing neutral CB1 antagonists from CB1 inverse agonists. The bioassay of CB1 receptor agonists relies on the ability of these ligands to produce concentration-related decreases in the amplitude of electrically evoked contractions of the vas deferens. This they do by acting on naturally expressed prejunctional neuronal CB1 receptors to inhibit release of the contractile neurotransmitters, noradrenaline and ATP, that is provoked by the electrical stimulation. The bioassay of competitive surmountable CB1 receptor antagonists involves determining the ability of these compounds to produce parallel dextral shifts in CB1 receptor agonist log concentration-response curves in electrically stimulated tissues. The mouse vas deferens has also been used to measure the ability of anandamide to activate vanilloid (TRPV1) receptors, to monitor modulation by cannabinoids such as 6″-azido-2″-yne and abnormal cannabidiol of contractions elicited in electrically unstimulated tissues by agonists for P2X purinoceptors or α1-adrenoceptors, and as a bioassay for the nonpsychoactive plant cannabinoid cannabidiol.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pertwee, R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129–180.
Pertwee, R. G., Coutts, A. A., Griffin, G., Fernando, S. R., McCallion, D., and Stevenson, L. (1996) Presence of cannabinoid CB1 receptors on prejunctional neurones of certain isolated tissue preparations: a brief review. Med. Sci. Monit. 2, 840–848.
Trendelenburg, A. U., Cox, S. L., Schelb, V., Klebroff, W., Khairallah, L., and Starke, K. (2000) Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues. Br. J. Pharmacol. 130, 321–330.
Schlicker, E. and Kathman, M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565–572.
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R., and Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161–202.
Schlicker, E., Redmer, A., Werner, A., and Kathmann, M. (2003) Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine. Br. J. Pharmacol. 140, 323–328.
von Kügelgen, I. and Starke, K. (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol. Sci. 12, 319–324.
Pertwee, R. G., Griffin, G., Lainton, J. A. H., and Huffman, J. W. (1995) Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol. 284, 241–247.
Pertwee, R. G., Fernando, S. R., Griffin, G., Ryan, W., Razdan, R. K., Compton, D. R., and Martin, B. R. (1996) Agonist-antagonist characterization of 6′-cyanohex-2′-yne-Δ8-tetrahydrocannabinol in two isolated tissue preparations. Pharmacol. 315, 195–201.
Pertwee, R. G., Fernando, S. R., Griffin, G., Abadji, V., and Makriyannis, A. (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol. 272, 73–78.
Thomas, A., Ross, R. A., Saha, B., Mahadevan, A., Razdan, R. K., and Pertwee, R. G. (2004) 6″-Azidohex-2″-yne-cannabidiol: a potential neutral, cannabinoid CB1 receptor antagonist. Eur. J. Pharmacol. 487, 213–221.
Pertwee, R. G., Ross, R. A., Craib, S. J., and Thomas, A. (2002) (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. Eur. J. Pharmacol. 456, 99–106.
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., and Pertwee, R. G. (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 132, 631–640.
Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R., and Corbett, A. D. (1992) Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol. 105, 980–984.
Tallarida, R. J., Cowan, A., and Adler, M. W. (1979) pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 25, 637–654.
Colquhoun, D. (1971) Lectures on Biostatistics, Oxford University Press, Oxford.
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., and Pertwee, R. G. (1997) Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol. 339, 53–61.
Westfall, T. D. and Westfall, D. P. (2001) Pharmacological techniques for the in vitro study of the vas deferens. J. Pharmacol. Toxicol. Methods 45, 109–122.
McMillan, K., Jolly, N., Bom, A., and Cottney, J. (2003) Effect of electrical field stimulation parameters on the potency of two cannabinoid agonists in the mouse vas deferens. Proc. Br. Pharmacol. Soc. at http://www.pa2online.org/Vol1Issue3abst043P.html.
Campbell, C., Jolly, N., Bom, A., and Cottney, J. (2003) The actions of six cannabinoid agonists in mouse vas deferens preparations under two different stimulation conditions. Proc. Br. Pharmacol. Soc. at http://www.pa2online.org/Vol1Issue3abst044P.html.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Thomas, A., Pertwee, R.G. (2006). The Bioassay of Cannabinoids Using the Mouse Isolated Vas Deferens. In: Onaivi, E.S. (eds) Marijuana and Cannabinoid Research. Methods In Molecular Medicine™, vol 123. Humana Press. https://doi.org/10.1385/1-59259-999-0:191
Download citation
DOI: https://doi.org/10.1385/1-59259-999-0:191
Publisher Name: Humana Press
Print ISBN: 978-1-58829-350-3
Online ISBN: 978-1-59259-999-8
eBook Packages: Springer Protocols